Conference Updates from IDWeek in San Francisco and IAS in Amsterdam

W. David Hardy, MD
Adjunct Professor of Medicine, Division of Infectious Diseases
Johns Hopkins University School of Medicine, Baltimore, MD

CME VIDEOTop of page

About the Presenter: Top of page

David Hardy received his medical degree from Baylor College of Medicine, Houston, TX and completed his residency in internal medicine at Harbor-UCLA Medical Center in Torrance, California. Early in the AIDS epidemic, he completed a clinical fellowship in infectious diseases/immunology and clinical research at the UCLA School of Medicine under the direction of Dr Michael Gottlieb, the physician who recognized and reported the first cases of AIDS. Later he also completed a laboratory fellowship in molecular retrovirology at the David Geffen School of Medicine at UCLA. Dr. Hardy has cared for persons with HIV infection since 1982 and conducted research on HIV and related diseases since 1984. Initially, he focused on treatment and prevention of opportunistic infections and currently on antiretroviral agents, immunotherapies and hepatitis treatments as well as retroviral vector research and gene therapy. Dr Hardy currently serves as Chair-Elect of the Board of Directors of the HIV Medicine Association (HIVMA) and will advance to Chair in 2018. Dr. Hardy also serves as Chair of the Education Committee of the American Academy of HIV Medicine (AAHIVM). He served as editor-in-chief of AAHIVM’s comprehensive clinical textbook, Fundamentals of HIV Medicine for the HIV Specialist published in 2007, 2008, 2012, 2017 and 2019.

Learning Objectives: Top of page

At the completion of this educational session, learners will:
  • Better appreciate new data regarding diagnosis and treatment of coinfections seen in PLWH.
  • Understand new developments regarding diagnosis, prevention and treatment of comorbidities seen in PLWH.
  • Be aware of how these coinfections and comorbidities impact mortality and morbidity of PLWH.

CME Information: Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ on November 13, 2018 and will terminate November 12, 2021.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
  • Accreditation Statement: Top of page

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

    The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

    Disclosure Statement:Top of page

    Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. W. David Hardy (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Gilead, Janssen, Merck, and ViiV; Advisory board member to Gilead, Merck, and ViiV. Dr. Hardy submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
  • Financial Support: Top of page

    This PRN CME activity is funded in part by unrestricted educational grants from: Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.

    How to Obtain CME Credit: Top of page

    This program will soon be available for CME on the PRN Courses Page at the Clinical Education Initiative Website of the New York State Department of Health, and we will add the link here, as soon as this is available. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.

    You must be logged in to post a comment. Login | Register